Etoposide-induced DNA damage in human tumor cells: requirement for cellular activating factors
- 23 September 1991
- journal article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Vol. 1097 (2) , 111-116
- https://doi.org/10.1016/0925-4439(91)90093-o
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutantsPublished by Elsevier ,2003
- Altered catalytic activity of and DNA cleavage by DNA topoisomerase II from human leukemic cells selected for resistance to VM-26Biochemistry, 1988
- Resistance to multiple chemotherapeutic agents in human cancer cellsTrends in Pharmacological Sciences, 1988
- The cell biology of multiple drug resistanceBiochemical Pharmacology, 1987
- Differential formation of hydroxyl radicals by adriamycin in sensitive and resistant MCF-7 human breast tumor cells: implications for the mechanism of actionBiochemistry, 1987
- In vitro metabolism of etoposide (VP-16-213) by liver microsomes and irreversible binding of reactive intermediates to microsomal proteinsBiochemical Pharmacology, 1987
- Homology between P-glycoprotein and a bacterial haemolysin transport protein suggests a model for multidrug resistanceNature, 1986
- Etoposide (VP-16–213)New England Journal of Medicine, 1985
- Comparison of cytotoxicity and DNA breakage activity of congeners of podophyllotoxin including VP16-213 and VM26: a quantitative structure-activity relationshipBiochemistry, 1984
- Effect of VP-16-213 on the intracellular degradation of DNA in HeLa cellsBiochemistry, 1976